www.360dx.com Open in urlscan Pro
104.18.29.67  Public Scan

Submitted URL: http://www.360dx.com/
Effective URL: https://www.360dx.com/
Submission: On September 16 via api from DE — Scanned from DE

Form analysis 2 forms found in the DOM

GET /elastic-search

<form action="/elastic-search" method="get" id="views-exposed-form-search-autocomplete-page" accept-charset="UTF-8">
  <div class="js-form-item form-item form-element__textfield">
    <input class="elastic-autocomplete-input form-autocomplete form-text form-item__textfield ui-autocomplete-input" placeholder="Enter your keywords" data-drupal-selector="edit-search-phrase"
      data-autocomplete-path="/admin/view_content/search_autocomplete" type="text" id="edit-search-phrase" name="search_phrase" value="" size="30" maxlength="128" data-once="autocomplete" autocomplete="off">
  </div>
  <div class="js-form-item form-item form-element__submit">
    <button class="button button--icon js-form-submit form-submit" aria-label="button" title="Search">
      <svg class="icon">
        <use xlink:href="/profiles/custom/crain_core/themes/custom/gweb/dist/icons.svg#magnifying-glass"></use>
      </svg>
    </button>
  </div>
  <div data-drupal-selector="edit-actions" class="form-actions js-form-wrapper form-wrapper" id="edit-actions"></div>
</form>

GET /elastic-search

<form action="/elastic-search" method="get" id="views-exposed-form-search-autocomplete-page" accept-charset="UTF-8">
  <div class="js-form-item form-item form-element__textfield">
    <input class="elastic-autocomplete-input form-autocomplete form-text form-item__textfield ui-autocomplete-input" placeholder="Enter your keywords" data-drupal-selector="edit-search-phrase"
      data-autocomplete-path="/admin/view_content/search_autocomplete" type="text" id="edit-search-phrase" name="search_phrase" value="" size="30" maxlength="128" data-once="autocomplete" autocomplete="off">
  </div>
  <div class="js-form-item form-item form-element__submit">
    <button class="button button--icon js-form-submit form-submit" aria-label="button" title="Search">
      <svg class="icon">
        <use xlink:href="/profiles/custom/crain_core/themes/custom/gweb/dist/icons.svg#magnifying-glass"></use>
      </svg>
    </button>
  </div>
  <div data-drupal-selector="edit-actions" class="form-actions js-form-wrapper form-wrapper" id="edit-actions"></div>
</form>

Text Content

Skip to main content


SISTER PUBLICATION LINKS

 * GenomeWeb
 * 360Dx
 * Precision Medicine Online
 * PMLS Events

 * RSS Feeds
 * Visit 360Dx on Twitter
 * Visit 360Dx on LinkedIn

Premium Trial:

Request an Annual Quote


USER ACCOUNT MENU

 * My 360Dx
   * Profile
   * Newsletters
   * My Topics
   * Reading List
   * Log out

Log in
Subscribe
Menu
Close Menu


MAIN NAVIGATION

 * My 360Dx
   * Profile
   * Newsletters
   * My Topics
   * Reading List
   * Log out
 * Business & Policy
   * Business News
   * Research Funding
   * Policy & Legislation
   * Regulatory News
   * Reimbursement
 * Clinical Lab Management
 * Diagnostics
   * Molecular Diagnostics
   * Immunoassays
   * Tissue-Based Testing
   * Clinical Chemistry
   * Hematology/Coagulation
   * Point-of-Care Testing
   * Companion Diagnostics
 * Disease Areas
   * Cancer
   * Infectious Disease
   * Cardiovascular Disease
   * Neurological & Psychological Disease
   * Autoimmune Disease
   * Inherited Disease
   * Reproductive Health
   * Respiratory
   * Gastrointestinal
   * COVID-19
 * Resources
   * Webinars
   * White Papers
   * Job Listings
   * New Products
   * People in the News
   * FDA 510(k) Tracker: IVD Tests and Instruments
   * Coronavirus Test Tracker
   * Partner Content




Premium Trial:

Request an Annual Quote

Log in
Subscribe



LACK OF STANDARDIZATION ACROSS MDX INFECTIOUS DISEASE TESTS COULD UNDERMINE
PANDEMIC PREPAREDNESS
PREMIUM

Poor cross-compatibility may make it difficult to substitute components of
automated sample processing and testing workflows in the case of shortages.


QUEST DIAGNOSTICS CONSUMER-INITIATED ALZHEIMER'S BLOOD TEST RAISING CONCERNS
AMONG EXPERTS
PREMIUM

Researchers and clinicians have highlighted the lack of data supporting the test
and warned that false positive results could further tax overburdened memory
clinics.


NY STATE DATABASE OFFERS GLIMPSE INTO LABORATORY-DEVELOPED TESTING LANDSCAPE
PREMIUM

Large national labs and applications like oncology, genetics, and infectious
disease dominate the database, which comprises more than 10,000 LDTs.


RESEARCHERS USE DNA NANOBALLS, BIOSENSORS TO CREATE LOW-COST DIAGNOSTICS
PREMIUM

The creation of DNA nanoballs allows for the use of more simplified detection
techniques, which potentially reduces the cost of testing.


SCIPHER MEDICINE TO EXPAND ARTHRITIS THERAPY RESPONSE TEST, AIMING TO MAXIMIZE
MEDICARE COVERAGE
PREMIUM

The company is collecting the data necessary to add at least two other drugs to
its current TNFi response predictor, which it believes will accelerate adoption.


DELVE BIO SEEKS TO COMMERCIALIZE UCSF METAGENOMIC PATHOGEN TEST
PREMIUM

In addition to proving clinical utility, the startup will have to navigate
issues of regulatory strategy, sequencing technology, and additional
indications.
Business, Policy & Funding


 * MEDTECH EUROPE CALLS FOR REFORMS TO IVDR, MDR REGULATIONS


 * IN BRIEF THIS WEEK: QUEST DIAGNOSTICS, DANAHER, TRINITY BIOTECH, ONCGNOSTICS,
   PRENETICS


 * SCIPHER MEDICINE TO EXPAND ARTHRITIS THERAPY RESPONSE TEST, AIMING TO
   MAXIMIZE MEDICARE COVERAGE
   PREMIUM


 * DELVE BIO SEEKS TO COMMERCIALIZE UCSF METAGENOMIC PATHOGEN TEST
   PREMIUM


 * QLUCORE MOVES CLOSER TO IVDR CERTIFICATION OF DX SOFTWARE FOR LEUKEMIA
   TESTING
   PREMIUM

Diagnostics


 * MEDTECH EUROPE CALLS FOR REFORMS TO IVDR, MDR REGULATIONS


 * SCIPHER MEDICINE TO EXPAND ARTHRITIS THERAPY RESPONSE TEST, AIMING TO
   MAXIMIZE MEDICARE COVERAGE
   PREMIUM


 * I-SPY 2 TRIAL TO EVALUATE NATERA'S SIGNATERA FOR POST-NEOADJUVANT BREAST
   CANCER MONITORING


 * RESEARCHERS USE DNA NANOBALLS, BIOSENSORS TO CREATE LOW-COST DIAGNOSTICS
   PREMIUM


 * MAINZ BIOMED STOCK SPIKES ON POSITIVE DATA FOR MRNA-ENHANCED COLORECTAL
   CANCER SCREENING ASSAY

Disease Areas


 * SCIPHER MEDICINE TO EXPAND ARTHRITIS THERAPY RESPONSE TEST, AIMING TO
   MAXIMIZE MEDICARE COVERAGE
   PREMIUM


 * I-SPY 2 TRIAL TO EVALUATE NATERA'S SIGNATERA FOR POST-NEOADJUVANT BREAST
   CANCER MONITORING


 * MAINZ BIOMED STOCK SPIKES ON POSITIVE DATA FOR MRNA-ENHANCED COLORECTAL
   CANCER SCREENING ASSAY


 * QLUCORE MOVES CLOSER TO IVDR CERTIFICATION OF DX SOFTWARE FOR LEUKEMIA
   TESTING
   PREMIUM


 * A3P BIOMEDICAL, BIOAGILYTIX PARTNER TO BRING PROSTATE CANCER TEST TO US

Clinical Lab Management


 * LOUISIANA LAB OWNER SENTENCED TO THREE YEARS IN FEDERAL PRISON FOR $45M LAB
   FRAUD SCHEME


 * LACK OF STANDARDIZATION ACROSS MDX INFECTIOUS DISEASE TESTS COULD UNDERMINE
   PANDEMIC PREPAREDNESS
   PREMIUM


 * QUEST DIAGNOSTICS CONSUMER-INITIATED ALZHEIMER'S BLOOD TEST RAISING CONCERNS
   AMONG EXPERTS
   PREMIUM


 * NY STATE DATABASE OFFERS GLIMPSE INTO LABORATORY-DEVELOPED TESTING LANDSCAPE
   PREMIUM


 * CHICAGO DOCTOR CONVICTED IN $9.5M GENETIC TESTING FRAUD CASE

Breaking News


 * LOUISIANA LAB OWNER SENTENCED TO THREE YEARS IN FEDERAL PRISON FOR $45M LAB
   FRAUD SCHEME


 * MEDTECH EUROPE CALLS FOR REFORMS TO IVDR, MDR REGULATIONS


 * IN BRIEF THIS WEEK: QUEST DIAGNOSTICS, DANAHER, TRINITY BIOTECH, ONCGNOSTICS,
   PRENETICS


 * I-SPY 2 TRIAL TO EVALUATE NATERA'S SIGNATERA FOR POST-NEOADJUVANT BREAST
   CANCER MONITORING


 * MAINZ BIOMED STOCK SPIKES ON POSITIVE DATA FOR MRNA-ENHANCED COLORECTAL
   CANCER SCREENING ASSAY


 * A3P BIOMEDICAL, BIOAGILYTIX PARTNER TO BRING PROSTATE CANCER TEST TO US



What's Popular?


 1. MEDTECH EUROPE CALLS FOR REFORMS TO IVDR, MDR REGULATIONS


 2. IN BRIEF THIS WEEK: QUEST DIAGNOSTICS, DANAHER, TRINITY BIOTECH,
    ONCGNOSTICS, PRENETICS


 3. RESEARCHERS USE DNA NANOBALLS, BIOSENSORS TO CREATE LOW-COST DIAGNOSTICS
    PREMIUM


 4. LACK OF STANDARDIZATION ACROSS MDX INFECTIOUS DISEASE TESTS COULD UNDERMINE
    PANDEMIC PREPAREDNESS
    PREMIUM


 5. QUEST DIAGNOSTICS CONSUMER-INITIATED ALZHEIMER'S BLOOD TEST RAISING CONCERNS
    AMONG EXPERTS
    PREMIUM




SPONSORSHIPS





FOOTER

 * About us
 * Advertise
 * Contact
 * FAQ
 * Jobs
 * Sitemap
 * Submit A Tip

Subscribe

Privacy Policy.  Terms & Conditions. Copyright © 2023 GenomeWeb, a business unit
of Crain Communications.  All Rights Reserved.

Our site uses cookies and related technologies, as described in our 
Datenschutzerklärung, for purposes that may include site operation, analytics,
enhanced user experience, or advertising. You may choose to consent to our use
of these technologies or manage your own preferences.
Akzeptieren Ablehnen Einstellungen verwalten